Free Trial

Trexquant Investment LP Acquires 46,094 Shares of Arteris, Inc. $AIP

Arteris logo with Computer and Technology background

Key Points

  • Trexquant Investment LP increased its stake in Arteris, Inc. by 22.9%, acquiring an additional 46,094 shares, bringing its total ownership to 247,041 shares, valued at approximately $1.7 million.
  • CEO K Charles Janac and COO Laurent R. Moll sold a total of 136,937 shares recently, indicating a decrease in executive ownership of the company stock.
  • Arteris reported a quarterly loss of ($0.11) EPS, matching analysts' expectations, while its revenue was slightly higher than estimated at $16.50 million.
  • Five stocks we like better than Arteris.

Trexquant Investment LP increased its holdings in shares of Arteris, Inc. (NASDAQ:AIP - Free Report) by 22.9% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 247,041 shares of the company's stock after buying an additional 46,094 shares during the quarter. Trexquant Investment LP owned 0.60% of Arteris worth $1,707,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of AIP. GAMMA Investing LLC raised its position in shares of Arteris by 11,823.3% during the first quarter. GAMMA Investing LLC now owns 5,127 shares of the company's stock worth $350,000 after acquiring an additional 5,084 shares during the last quarter. CWM LLC grew its stake in Arteris by 4,810.1% in the first quarter. CWM LLC now owns 10,213 shares of the company's stock valued at $71,000 after acquiring an additional 10,005 shares during the period. D. E. Shaw & Co. Inc. bought a new position in shares of Arteris in the fourth quarter valued at approximately $110,000. Price T Rowe Associates Inc. MD bought a new position in shares of Arteris in the fourth quarter valued at approximately $117,000. Finally, Wells Fargo & Company MN lifted its holdings in shares of Arteris by 38.9% in the fourth quarter. Wells Fargo & Company MN now owns 13,192 shares of the company's stock valued at $134,000 after purchasing an additional 3,694 shares in the last quarter. 64.36% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, COO Laurent R. Moll sold 42,692 shares of Arteris stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $8.94, for a total value of $381,666.48. Following the sale, the chief operating officer directly owned 399,379 shares of the company's stock, valued at approximately $3,570,448.26. The trade was a 9.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Saiyed Atiq Raza sold 63,118 shares of Arteris stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $13.07, for a total value of $824,952.26. Following the completion of the sale, the director directly owned 590,000 shares in the company, valued at $7,711,300. This trade represents a 9.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 510,616 shares of company stock valued at $5,979,663 over the last three months. 29.10% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

AIP has been the subject of several research analyst reports. TD Cowen raised their target price on Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Wall Street Zen lowered Arteris from a "hold" rating to a "sell" rating in a research note on Sunday. Finally, Rosenblatt Securities restated a "buy" rating and set a $14.00 target price on shares of Arteris in a research report on Wednesday, May 21st. Three research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Arteris currently has an average rating of "Buy" and a consensus target price of $15.00.

Get Our Latest Stock Report on AIP

Arteris Stock Down 0.7%

Shares of NASDAQ:AIP traded down $0.06 during trading on Wednesday, hitting $8.66. The stock had a trading volume of 663,249 shares, compared to its average volume of 536,202. Arteris, Inc. has a 12 month low of $5.46 and a 12 month high of $14.29. The company has a market capitalization of $369.35 million, a PE ratio of -10.56 and a beta of 1.44. The firm's fifty day moving average is $9.49 and its 200 day moving average is $8.22.

Arteris (NASDAQ:AIP - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The company had revenue of $16.50 million during the quarter, compared to analyst estimates of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts expect that Arteris, Inc. will post -0.73 EPS for the current fiscal year.

Arteris Profile

(Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Recommended Stories

Institutional Ownership by Quarter for Arteris (NASDAQ:AIP)

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.